Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide

Mutagenesis

Volumn 26, Issue 4, 2011, Pages 489-498

  López Lázaro, Miguel ^a,b   Calderón Montaño, José Manuel ^b   Burgos Morón, Estefanía ^b   Austin, Caroline A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); EPIGALLOCATECHIN GALLATE; GALLIC ACID; HYDROGEN PEROXIDE; MYRICETIN; PYROGALLOL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN K 562; CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LEUKEMIA; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TEA;

ANIMALS; BIOCATALYSIS; CATALASE; CATECHIN; CELL DEATH; CELL LINE; DNA; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; FLAVONOIDS; GALLIC ACID; HUMANS; HYDROGEN PEROXIDE; MICE; MODELS, BIOLOGICAL; PYROGALLOL; TEA; TIME FACTORS;

EID: 79959737365     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger006     Document Type: Article

References (63)

1. Yang, C. S., Wang, X., Lu, G. and Picinich, S. C. (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer, 9, 429-439.
2. Clement, Y. (2009) Can green tea do that? A literature review of the clinical evidence. Prev. Med., 49, 83-87.
3. Khan, N., Afaq, F., Saleem, M., Ahmad, N. and Mukhtar, H. (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin- 3-gallate. Cancer Res., 66, 2500-2505.
4. Khan, N. and Mukhtar, H. (2008) Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett., 269, 269-280.
5. Mandel, S. A., Amit, T., Kalfon, L., Reznichenko, L., Weinreb, O. and Youdim, M. B. (2008) Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J. Alzheimers. Dis., 15, 211-222.
6. Wolfram, S. (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr., 26, 373S-388S.
7. Moon, H. S., Lee, H. G., Choi, Y. J., Kim, T. G. and Cho, C. S. (2007) Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity. Chem. Biol. Interact., 167, 85-98.
8. Champoux, J. J. (2001) DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem., 70, 369-413369-413.
9. Wang, J. C. (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol., 3, 430-440.
10. Fortune, J. M. and Osheroff, N. (2000) Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog. Nucleic Acid Res. Mol. Biol., 64, 221-253.
11. Felix, C. A. (2001) Leukemias related to treatment with DNA topoisomerase II inhibitors. Med. Pediatr. Oncol., 36, 525-535.
12. Felix, C. A. (1998) Secondary leukemias induced by topoisomerase-targeted drugs. Biochim. Biophys. Acta, 1400, 233-255.
13. Mistry, A. R., Felix, C. A., Whitmarsh, R. J. et al. (2005) DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N. Engl. J Med., 352, 1529-1538. (Pubitemid 40517093)
14. Hofland, K. F., Thougaard, A. V., Sehested, M. and Jensen, P. B. (2005) Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin. Clin. Cancer Res., 11, 3915-3924.
15. Austin, C. A., Patel, S., Ono, K., Nakane, H. and Fisher, L. M. (1992) Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem. J., 282, 883-889.
16. Berger, S. J., Gupta, S., Belfi, C. A., Gosky, D. M. and Mukhtar, H. (2001) Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Biochem. Biophys. Res. Commun., 288, 101-105.
17. Suzuki, K., Yahara, S., Hashimoto, F. and Uyeda, M. (2001) Inhibitory activities of (-)-epigallocatechin-3-O-gallate against topoisomerases I and II. Biol. Pharm. Bull., 24, 1088-1090.
18. Bandele, O. J., Clawson, S. J. and Osheroff, N. (2008) Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement. Chem. Res. Toxicol., 21, 1253-1260.
19. Bandele, O. J. and Osheroff, N. (2008) (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases. Chem. Res. Toxicol., 21, 936-943.
20. Neukam, K., Pastor, N. and Cortes, F. (2008) Tea flavanols inhibit cell growth and DNA topoisomerase II activity and induce endoreduplication in cultured Chinese hamster cells. Mutat. Res., 654, 8-12.
21. Ramirez-Mares, M. V., Chandra, S. and de Mejia, E. G. (2004) In vitro chemopreventive activity of Camellia sinensis, Ilex paraguariensis and Ardisia compressa tea extracts and selected polyphenols. Mutat. Res., 554, 53-65.
22. Hwang, Y., Rhodes, D. and Bushman, F. (2000) Rapid microtiter assays for poxvirus topoisomerase, mammalian type IB topoisomerase and HIV-1 integrase: application to inhibitor isolation. Nucleic Acids Res., 28, 4884-4892. (Pubitemid 32014258)
23. Sordet, O., Khan, Q. A., Kohn, K. W. and Pommier, Y. (2003) Apoptosis induced by topoisomerase inhibitors. Curr. Med. Chem. Anticancer Agents, 3, 271-290.
24. Furukawa, A., Oikawa, S., Murata, M., Hiraku, Y. and Kawanishi, S. (2003) (-)-Epigallocatechin gallate causes oxidative damage to isolated and cellular DNA. Biochem. Pharmacol., 66, 1769-1778.
25. Elbling, L., Weiss, R. M., Teufelhofer, O. et al. (2005) Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J., 19, 807-809. (Pubitemid 40617391)
26. Bertram, B., Bollow, U., Rajaee-Behbahani, N., Burkle, A. and Schmezer, P. (2003) Induction of poly(ADP-ribosyl)ation and DNA damage in human peripheral lymphocytes after treatment with (-)-epigallocatechin-gallate. Mutat. Res., 534, 77-84.
27. Ahmad, N., Feyes, D. K., Nieminen, A. L., Agarwal, R. and Mukhtar, H. (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl Cancer Inst., 89, 1881-1886. (Pubitemid 28009824)
28. Lu, Y. P., Lou, Y. R., Xie, J. G. et al. (2002) Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. USA, 99, 12455-12460.
29. Chowdhury, A. R., Sharma, S., Mandal, S., Goswami, A., Mukhopadhyay, S. and Majumder, H. K. (2002) Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem. J., 366, 653-661.
30. Lopez-Lazaro, M., Willmore, E. and Austin, C. A. (2007) Cells lacking DNA topoisomerase II beta are resistant to genistein. J. Nat. Prod., 70, 763-767.
31. Errington, F., Willmore, E., Tilby, M. J. et al. (1999) Murine transgenic cells lacking DNA topoisomerase IIbeta are resistant to acridines and mitoxantrone: analysis of cytotoxicity and cleavable complex formation. Mol. Pharmacol., 56, 1309-1316.
32. Willmore, E., Frank, A. J., Padget, K., Tilby, M. J. and Austin, C. A. (1998) Etoposide targets topoisomerase IIalpha and IIbeta in leukemic cells: isoform-specific cleavable complexes visualized and quantified in situ by a novel immunofluorescence technique. Mol. Pharmacol., 54, 78-85.
33. Padget, K., Carr, R., Pearson, A. D., Tilby, M. J. and Austin, C. A. (2000) Camptothecin-stabilised topoisomerase I-DNA complexes in leukaemia cells visualised and quantified in situ by the TARDIS assay (trapped in agarose DNA immunostaining). Biochem. Pharmacol., 59, 629-638.
34. Cowell, I. G., Tilby, M. J. and Austin, C. A. (2011) An overview of the visualisation and quantitation of low and high MW DNA adducts using the trapped in agarose DNA immunostaining (TARDIS) assay. Mutagenesis, 26, 253-260.
35. Lopez-Lazaro, M., Willmore, E., Jobson, A. et al. (2007) Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells. J. Nat. Prod., 70, 1884-1888.
36. Lopez-Lazaro, M., Willmore, E. and Austin, C. A. (2010) The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells. Mutat. Res., 696, 41-47.
37. Chan, M. M., Soprano, K. J., Weinstein, K. and Fong, D. (2006) Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J. Cell. Physiol., 207, 389-396.
38. Nakagawa, H., Hasumi, K., Woo, J. T., Nagai, K. and Wachi, M. (2004) Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis, 25, 1567-1574. (Pubitemid 39214298)
39. Daroui, P., Desai, S. D., Li, T. K., Liu, A. A. and Liu, L. F. (2004) Hydrogen peroxide induces topoisomerase I-mediated DNA damage and cell death. J. Biol. Chem., 279, 14587-14594.
40. Li, T. K., Chen, A. Y., Yu, C., Mao, Y., Wang, H. and Liu, L. F. (1999) Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress. Genes Dev., 13, 1553-1560.
41. Brusselmans, K., De Schrijver, E., Heyns, W., Verhoeven, G. and Swinnen, J. V. (2003) Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Int. J. Cancer, 106, 856-862.
42. Paul, B., Hayes, C. S., Kim, A., Athar, M. and Gilmour, S. K. (2005) Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice. Carcinogenesis, 26, 119-124.
43. Vergote, D., Cren-Olive, C., Chopin, V. et al. (2002) (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Breast Cancer Res. Treat., 76, 195-201.
44. Inoue, M., Suzuki, R., Sakaguchi, N. et al. (1995) Selective induction of cell death in cancer cells by gallic acid. Biol. Pharm. Bull., 18, 1526-1530.
45. Lopez-Lazaro, M., Willmore, E., Elliott, S. L. and Austin, C. A. (2008) Selenite induces topoisomerase I and II-DNA complexes in K562 leukemia cells. Int. J. Cancer, 123, 2217-2221.
46. Mochizuki, M., Yamazaki, S., Kano, K. and Ikeda, T. (2002) Kinetic analysis and mechanistic aspects of autoxidation of catechins. Biochim. Biophys. Acta, 1569, 35-44.
47. Akagawa, M., Shigemitsu, T. and Suyama, K. (2003) Production of hydrogen peroxide by polyphenols and polyphenol-rich beverages under quasi-physiological conditions. Biosci. Biotechnol. Biochem., 67, 2632-2640.
48. Sordet, O., Liao, Z., Liu, H. et al. (2004) Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis. J. Biol. Chem., 279, 33968-33975.
49. Sordet, O., Goldman, A. and Pommier, Y. (2006) Topoisomerase II and tubulin inhibitors both induce the formation of apoptotic topoisomerase I cleavage complexes. Mol. Cancer Ther., 5, 3139-3144.
50. Sordet, O., Goldman, A., Redon, C., Solier, S., Rao, V. A. and Pommier, Y. (2008) Topoisomerase I requirement for death receptor-induced apoptotic nuclear fission. J. Biol. Chem., 283, 23200-23208.
51. Inoue, M., Suzuki, R., Koide, T., Sakaguchi, N., Ogihara, Y. and Yabu, Y. (1994) Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem. Biophys. Res. Commun., 204, 898-904.
52. Wang, I. K., Lin-Shiau, S. Y. and Lin, J. K. (1999) Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer, 35, 1517-1525.
53. Park, W. H., Han, Y. W., Kim, S. H. and Kim, S. Z. (2007) A superoxide anion generator, pyrogallol induces apoptosis in As4.1 cells through the depletion of intracellular GSH content. Mutat. Res., 619, 81-92.
54. Saeki, K., Hayakawa, S., Isemura, M. and Miyase, T. (2000) Importance of a pyrogallol-type structure in catechin compounds for apoptosis-inducing activity. Phytochemistry, 53, 391-394. (Pubitemid 30096922)
55. Ahmad, K. A., Iskandar, K. B., Hirpara, J. L., Clement, M. V. and Pervaiz, S. (2004) Hydrogen peroxide-mediated cytosolic acidification is a signal for mitochondrial translocation of Bax during drug-induced apoptosis of tumor cells. Cancer Res., 64, 7867-7878. (Pubitemid 39446920)
56. Ikeda, K., Kajiwara, K., Tanabe, E. et al. (1999) Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells. Biochem. Pharmacol., 57, 1361-1365.
57. Kajiwara, K., Ikeda, K., Kuroi, R., Hashimoto, R., Tokumaru, S. and Kojo, S. (2001) Hydrogen peroxide and hydroxyl radical involvement in the activation of caspase-3 in chemically induced apoptosis of HL-60 cells. Cell Mol. Life Sci., 58, 485-491.
58. Lopez-Lazaro, M. (2007) Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett., 252, 1-8.
59. Schumacker, P. T. (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell, 10, 175-176.
60. Chen, Q., Espey, M. G., Krishna, M. C. et al. (2005) Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a prodrug to deliver hydrogen peroxide to tissues. Proc. Natl Acad. Sci. USA, 102, 13604-13609.
61. Jing, Y., Dai, J., Chalmers-Redman, R. M., Tatton, W. G. and Waxman, S. (1999) Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood, 94, 2102-2111. (Pubitemid 29430427)
62. Lopez-Lazaro, M. (2010) A new view of carcinogenesis and an alternative approach to cancer therapy. Mol. Med., 16, 144-153.
63. Yang, C. J., Wang, C. S., Hung, J. Y. et al. (2009) Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model. Lung Cancer, 66, 162-168.